Middle East News Digest
SEE OTHER BRANDS

Your daily news update on the Middle East

Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on March 19, 2025

Wix Launches Wix Functions to Customize Business Logic Without Code

Wix Launches Wix Functions to Customize Business Logic Without Code

Wix Functions empowers users to create customized business flows, automate pricing and checkout rules, and tailor app behavior NEW YORK – Wix.com Ltd. (NASDAQ: WIX), the leading SaaS website builder platform globally1, today launched Wix Functions, a no- …

Grip Security Partners with IDMWORKS to Redefine Identity and Access Management for the SaaS Era

Grip Security Partners with IDMWORKS to Redefine Identity and Access Management for the SaaS Era

BOSTON, March 19, 2025 (GLOBE NEWSWIRE) -- Grip Security, a leader in SaaS identity risk management, today announced a strategic partnership with IDMWORKS, a global leader in identity and access management (IAM). The partnership addresses the complex …

Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson

Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson

FDA …

BOS Announces the Appointment of Osnat Gur as Board Chair and Avi Dadon as Independent Director

BOS Announces the Appointment of Osnat Gur as Board Chair and Avi Dadon as Independent Director

RISHON LE ZION, Israel, March 19, 2025 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC), a global integrator of supply chain technologies, today announced the appointment of Osnat Gur, currently an independent …

Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session

Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session

SOUTH SAN FRANCISCO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …

Lirum Therapeutics Invited to Present at Prestigious Gordon Research Conference

Lirum Therapeutics Invited to Present at Prestigious Gordon Research Conference

New York, NY, March 19, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that the Company has been invited to present at …

REE Automotive unterzeichnet Absichtserklärung für softwaredefinierte Technologie mit einem der führenden Technologieunternehmen und ebnet damit den Weg für ein mehrjähriges Rahmenabkommen für die Serienfertigung autonomer Fahrzeuge

REE Automotive unterzeichnet Absichtserklärung für softwaredefinierte Technologie mit einem der führenden Technologieunternehmen und ebnet damit den Weg für ein mehrjähriges Rahmenabkommen für die Serienfertigung autonomer Fahrzeuge

REE soll als exklusiver Anbieter von softwaredefinierter Fahrzeugtechnologie für dieses führende Technologieunternehmen in mehreren globalen Märkten agieren Eine verbindliche langfristige Kooperationsvereinbarung soll im Jahr 2025 mit dem Ziel …

Acumen Pharmaceuticals Announces Topline Results from Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers

Acumen Pharmaceuticals Announces Topline Results from Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers

Weekly subcutaneous administration of sabirnetug was well-tolerated in the Phase 1 study Systemic exposure following subcutaneous administration supports further clinical development Development of sabirnetug delivered subcutaneously has the potential for …

Refined Energy Corp Announces Uplisting on the OTCQB

Refined Energy Corp Announces Uplisting on the OTCQB

VANCOUVER, British Columbia, March 19, 2025 (GLOBE NEWSWIRE) -- Refined Energy Corp. (CSE: RUU | OTC: RRUUF | FRA: CWA0) ("Refined” or the "Company") is pleased to announce that it has successfully upgraded from the OTC Pink Market to the OTCQB Venture …

Pan American Energy Closes Private Placements for Gross Proceeds of Approximately $1.02M

Pan American Energy Closes Private Placements for Gross Proceeds of Approximately $1.02M

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (CSE: PNRG | FRA: SS60) (“Pan American” or the “Company”) announces that it …

GigaOm Recognizes Infinidat as a Leader and a Fast Mover in Storage as a Service

GigaOm Recognizes Infinidat as a Leader and a Fast Mover in Storage as a Service

WALTHAM, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that GigaOm, a leading IT analyst firm, has recognized Infinidat as a Leader and a Fast Mover in the 2025 GigaOm Sonar Report …

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

CINCINNATI, March 19, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) (“Onconetix” or the “Company”), (formerly Blue Water Biotech, Inc. (BWV)), a cancer diagnostics company focused on the research, development and commercialization of innovative …

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

Aiming to improve bioavailability and optimize the therapeutic effect of Clearmind’s psychedelic-based treatments Vancouver, Canada, March 19, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a …

American Tungsten Corp. Secures Strategic Partnership Agreement with J.A. Green

American Tungsten Corp. Secures Strategic Partnership Agreement with J.A. Green

Vancouver, BC, March 19, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce that it has entered into a strategic partnership agreement (“Agreement”) with J.A. …

Novacium's Silicon-Anode Batteries Exceed 1,000 Cycles, Outperforming Commercial 18650 Cells

Novacium's Silicon-Anode Batteries Exceed 1,000 Cycles, Outperforming Commercial 18650 Cells

MONTREAL, March 19, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in green engineering processes is excited to update shareholders on the latest battery results at …

Les Batteries à Base de Silicium de Novacium Dépassent les 1 000 cycles Surpassant les Batteries 18650 Commercial

Les Batteries à Base de Silicium de Novacium Dépassent les 1 000 cycles Surpassant les Batteries 18650 Commercial

MONTRÉAL, 19 mars 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’ingénierie verte des procédés a le plaisir d’informer ses actionnaires des …

Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas

Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas

New Plasma Collection Center in San Antonio has Planned Annual Collection Capacity of Approximately 50,000 Liters Center Will Collect Normal Source Plasma and Specialty Plasma, such as Anti-Rabies and Anti-D Specialty Plasma Collected will Support the …

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

-Durable, Clinically Significant Improvements in Swallowing Function Achieved 12-months Post-Treatment with BB-301 for Subject 1- -Durable, Clinically Significant Improvements in Swallowing Function Achieved 12-months Post-Treatment with BB-301 for Subject …

Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements

Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements

$65 million in Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly …

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced the appointment of Todd F. Baumgartner, MD, MPH as Chief …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service